FDA Clears At-Home HPV Screening Tool - Summary - MDSpire

FDA Clears At-Home HPV Screening Tool

Self-collection approach aims to expand screening access

  • By

  • Kathryn Wighton

  • April 8, 2026

  • 2 min

Share

Objective:

To increase access to cervical cancer screening through the FDA's approval of the Onclarity HPV self-collection kit and the BD Onclarity HPV Assay for at-home use.

Key Findings:
  • Cervical cancer is preventable with routine screening and early identification of HPV, which is linked to nearly all cases.
  • Approximately 60% of cervical cancer cases occur in unscreened or under-screened patients.
  • At-home sample collection may improve screening participation and access.
Interpretation:

The introduction of at-home HPV screening tools is expected to enhance access to cervical cancer screening and facilitate earlier detection.

Limitations:
  • The effectiveness of the self-collection kit in increasing screening rates remains to be fully evaluated.
  • Potential barriers to access and adherence, such as patient education and healthcare provider engagement, may still exist despite the new options.
Conclusion:

The FDA's approval of the at-home HPV screening tool aims to improve cervical cancer screening uptake and support timely patient management, potentially leading to earlier detection.

Original Source(s)

FDA Clears At-Home HPV Screening Tool

  • by Kathryn Wighton

  • April 8, 2026

Related Content

Physicians Exiting Practice Earlier

Researchers identify burnout-associated workplace pressures and caregiving responsibilities as major contributors to physician attrition.

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

Genes May Help Identify Severe Male Infertility

Three amino acid metabolism genes showed diagnostic signal in testicular tissue, though small sample sizes and computational methods limit clinical translation.